A Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in Public Acute Care Hospitals in Crete, Greece

被引:9
|
作者
Ioannou, Petros [1 ]
Astrinaki, Eirini [2 ]
Vitsaxaki, Efsevia [2 ]
Bolikas, Emmanouil [3 ]
Christofaki, Despoina [4 ]
Salvaraki, Apostolia [5 ]
Lagoudaki, Eirini [6 ]
Ioannidou, Eleni [5 ]
Karakonstantis, Stamatis [1 ]
Saplamidou, Stamatina [2 ]
Cleovoulou, Christos [6 ]
Stamataki, Eleni [6 ]
Ilia, Stavroula [7 ,8 ]
Messaritaki, Argyri [9 ]
Avdi, Michaela [10 ]
Chalkiadaki, Anthoula [4 ]
Papathanasaki, Styliani [11 ]
Markopoulou, Chrisanthi [12 ]
Magouli, Evagelia [13 ]
Moustaki, Maria [11 ]
Kataxaki, Vasileia-Athina [11 ]
Skevakis, Panagiotis [14 ]
Spernovasilis, Nikolaos [8 ,15 ]
Chamilos, Georgios [16 ]
Kofteridis, Diamantis P. [1 ]
机构
[1] Univ Hosp Heraklion, Dept Internal Med, Iraklion 71500, Greece
[2] Univ Hosp Heraklion, Infect Control Comm, Iraklion 71500, Greece
[3] Venizeleio Pananeio Gen Hosp Heraklion, Infect Control Comm, Iraklion 71409, Greece
[4] Gen Hosp Hlth Ctr Neapoli Dialinakio, Gen Hosp Lasithi, Infect Control Comm, Organ Unit Agios Nikolaos, Agios Nikolaos 72100, Greece
[5] Gen Hosp Rethymno, Infect Control Comm, Rethimnon 74132, Greece
[6] Gen Hosp Chania St George, Infect Control Comm, Khania 73300, Greece
[7] Univ Hosp Heraklion, Pediat Intens Care Unit, Iraklion 71500, Greece
[8] Univ Crete, Sch Med, Iraklion 71500, Greece
[9] Univ Hosp Heraklion, Off Nursing Serv, Iraklion 71500, Greece
[10] Gen Hosp Rethymno, Internal Med, Rethimnon 74132, Greece
[11] Gen Hosp Hlth Ctr Neapoli Dialinakio, Gen Hosp Lasithi, Infect Control Comm, Decentralized Organ Unit Sitia, Sitia 72300, Greece
[12] Gen Hosp Hlth Ctr Neapoli Dialinakio, Gen Hosp Lasithi, Infect Control Comm, Decentralized Organ Unit Ierapetra, Ierapetra 72200, Greece
[13] Gen Hosp Hlth Care Ctr Neapoli Dialinakeio, Infect Control Comm, Neapoli 72400, Greece
[14] Collaborat Ctr Clin Epidemiol & Outcomes Res CLEO, Athens 15451, Greece
[15] German Oncol Ctr, CY-4108 Limassol, Cyprus
[16] Univ Hosp Heraklion, Dept Clin Microbiol, Iraklion 71500, Greece
来源
ANTIBIOTICS-BASEL | 2022年 / 11卷 / 09期
关键词
infection control; point prevalence survey; antimicrobial stewardship; COVID-19; hospital acquired infection; antimicrobial resistance; LONG-TERM; CONTROL PROGRAMS; PREVENTION; IMPACT; REQUIREMENTS; SURVEILLANCE; CONSUMPTION; RESISTANCE; COVID-19; NETWORK;
D O I
10.3390/antibiotics11091258
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Both healthcare-associated infections (HAIs) and antimicrobial resistance are associated with an increased length of stay and hospital costs, while they have also been linked to high morbidity and mortality rates. In 2016 and 2017, the latest point prevalence survey (PPS) of HAIs and antimicrobial use in European acute care hospitals highlighted an HAI prevalence of 6.5%, while Greece had a higher HAI prevalence of 10%. The aim of this PPS was to record the prevalence of HAIs and antimicrobial use in all eight public acute care hospitals in Crete, Greece during the COVID-19 pandemic in order to highlight the types of infections and antimicrobial practices that need to be prioritized for infection control initiatives. Methods: The PPS was conducted between 30 March and 15 April 2022, according to the ECDC standardized relevant protocol (version 5.3). Statistics were extracted using the ECDC Helics.Win.Net application (software version 4.1.0). Results: A total of 1188 patients were included. The overall point prevalence of patients with at least one HAI was 10.6%. The most frequent types of infections were pneumonia (34.3%), bloodstream infections (10.5%), systemic infections and urinary tract infections (10.5% and 9.1%, respectively). In 14 (12.4%) cases, the pathogen responsible for HAI was SARS-CoV-2 following onsite spread, accounting for almost 10% of all HAIs. Microorganisms were identified in 60.1% of HAIs. Antimicrobials were administered in 711 (59.8%) patients, with 1.59 antimicrobials used per patient. Conclusion: The prevalence of HAI and antimicrobial use among hospitalized patients in Crete, Greece was similar to the national HAI prevalence in 2016 despite the enormous pressure on public hospitals due to the COVID-19 pandemic. Nevertheless, both HAI prevalence and antimicrobial use remain high, underlining the need to implement adequate infection control and antimicrobial stewardship interventions.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Point prevalence survey of antibiotic use and healthcare-associated infections in acute care hospitals: a comprehensive report from the Marche Region of Italy
    Barbadoro, P.
    Dolcini, J.
    Fortunato, C.
    Rinaldini, D. Mengarelli detto
    Martini, E.
    Gioia, M. G.
    Mengoni, D.
    D'Errico, M. M.
    JOURNAL OF HOSPITAL INFECTION, 2023, 141 : 80 - 87
  • [22] Prevalence of Healthcare-Associated Infections in Acute Care Hospitals in Jacksonville, Florida
    Magill, Shelley S.
    Hellinger, Walter
    Cohen, Jessica
    Kay, Robyn
    Bailey, Christine
    Boland, Bonnie
    Carey, Darlene
    de Guzman, Jessica
    Dominguez, Karen
    Edwards, Jonathan
    Goraczewski, Lori
    Horan, Teresa
    Miller, Melodee
    Phelps, Marti
    Saltford, Rebecca
    Seibert, Jacquelyn
    Smith, Brenda
    Starling, Patricia
    Viergutz, Bonnie
    Walsh, Karla
    Rathore, Mobeen
    Guzman, Nilmarie
    Fridkin, Scott
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2012, 33 (03): : 283 - 291
  • [23] Prevalence of antimicrobial use and healthcare-associated infections in China: Results from the first point prevalence survey in 18 hospitals in Shanxi Province
    Li, Xiaoxia
    Cai, Wanni
    Song, Yan
    Kang, Jianbang
    Ji, Xiaopeng
    Tian, Fangying
    Yin, Donghong
    Wang, Shuyun
    Guo, Qian
    Song, Junli
    Shi, Nan
    Duan, Jinju
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 33 : 283 - 290
  • [24] Prevalence of healthcare-associated infections and antimicrobial use in China: Results from the 2018 point prevalence survey in 189 hospitals in Guangdong Province
    Zhang, Yu
    Zhong, Zhen-Feng
    Chen, Shu-Xian
    Zhou, Dian-Rong
    Li, Zheng-Kang
    Meng, Yue
    Zhou, Jing-Fang
    Hou, Tie-Ying
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 89 : 179 - 184
  • [25] Pilot Survey for National Point Prevalence Study of Healthcare-Associated Infections in Acute-Care Hospitals in South Korea
    Lee, Ji Young
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S350 - S351
  • [26] Prevalence of healthcare-associated infections and antimicrobial use among inpatients in a tertiary hospital in Fiji: a point prevalence survey
    M. J. Loftus
    S. J. Curtis
    R. Naidu
    A. C. Cheng
    A. W. J. Jenney
    B. G. Mitchell
    P. L. Russo
    E. Rafai
    A. Y. Peleg
    A. J. Stewardson
    Antimicrobial Resistance & Infection Control, 9
  • [27] Prevalence of healthcare-associated infections and antimicrobial use among inpatients in a tertiary hospital in Fiji: a point prevalence survey
    Loftus, M. J.
    Curtis, S. J.
    Naidu, R.
    Cheng, A. C.
    Jenney, A. W. J.
    Mitchell, B. G.
    Russo, P. L.
    Rafai, E.
    Peleg, A. Y.
    Stewardson, A. J.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2020, 9 (01)
  • [28] A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria
    Luigi Segagni Lusignani
    Alexander Blacky
    Peter Starzengruber
    Magda Diab-Elschahawi
    Thomas Wrba
    Elisabeth Presterl
    Wiener klinische Wochenschrift, 2016, 128 : 89 - 94
  • [29] A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria
    Lusignani, Luigi Segagni
    Blacky, Alexander
    Starzengruber, Peter
    Diab-Elschahawi, Magda
    Wrba, Thomas
    Presterl, Elisabeth
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (3-4) : 89 - 94
  • [30] Antimicrobial use, healthcare-associated infections, and bacterial resistance in general hospitals in China: the first national pilot point prevalence survey report
    Xiao, Yonghong
    Xin, Xing
    Chen, Yunbo
    Yan, Qing
    China PPS team
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (06) : 715 - 726